About Quotient Sciences
Quotient Sciences is a company based in Nottingham (United Kingdom) founded in 1990 was acquired by Permira in July 2019. The company has 369 employees as of December 31, 2022. Quotient Sciences has completed 3 acquisitions, including Arc Trinova, QS Pharma and SeaView Research. Quotient Sciences operates in a competitive market with competitors including Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
- Headquarter Nottingham, United Kingdom
- Employees 369 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Permira
& 1 more
-
Employee Count
369
as on Dec 31, 2022
-
Investments & Acquisitions
Arc Trinova
& 2 more
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Quotient Sciences
Detailed funding history for Quotient Sciences
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Quotient Sciences
Quotient Sciences has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Permira and Bridgepoint Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Locked | Locked | Locked | |
|
Middle-market businesses up to €1 billion are acquired pan-Europe.
|
Locked | Locked | Locked |
Investor details for Quotient Sciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Quotient Sciences
Quotient Sciences has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Arc Trinova, QS Pharma and SeaView Research.
Investment portfolio details for Quotient Sciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Contract manufacturing, bioanalytical, and consulting services are provided.
|
Locked | Locked | 2016 | Locked | |
|
Contract development and manufacturing for small molecule pharmaceuticals are offered.
|
Locked | Locked | 2002 | Locked | |
|
Early stage CRO, also offering clinical pharmacology testing and laboratory services
|
Locked | Locked | 1995 | Locked |
Complete acquisition details for Quotient Sciences
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Quotient Sciences
Detailed financials for Quotient Sciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Quotient Sciences Comparisons
Peer comparison for Quotient Sciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Quotient Sciences
Quotient Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nephron Pharmaceuticals, Enzene Biosciences, Hybio Pharmaceutical, AmbioPharm and Suanfarma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sterile pharmaceutical products are manufactured and contract services are provided.
|
|
| Locked | Locked | Locked |
Company specializing in development of Biosimilars
|
|
| Locked | Locked | Locked |
Polypeptide drugs and APIs are developed and manufactured.
|
|
| Locked | Locked | Locked |
CDMO and analytical services for peptide development are provided.
|
|
| Locked | Locked | Locked |
Generics, nutraceuticals, and APIs are developed by Suanfarma.
|
|
| Locked | Locked | Locked |
Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions
|
Detailed competitors of Quotient Sciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Quotient Sciences
Complete news archive for Quotient Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Quotient Sciences
Quotient Sciences was founded in 1990.
Quotient Sciences is headquartered in Nottingham, United Kingdom.
As of Dec 31, 2022, the latest employee count at Quotient Sciences is 369.
Quotient Sciences was founded in 1990 and is headquartered in Nottingham, United Kingdom. Operations focus on the pharmaceutical sector, where APIs and various finished dosage formsincluding tablets, capsules, liquids, inhaled, topical, rectal, and parenteral productsare developed and manufactured. Services encompass formulation design, pre-formulation screening, first-in-human studies, solubility enhancement, modified release technologies, analytical support, process optimization, and clinical trial manufacturing.
Quotient Sciences's top competitors include Nephron Pharmaceuticals, Suanfarma and Enzene Biosciences.
Quotient Sciences has made 3 acquisitions, including Arc Trinova, QS Pharma, and SeaView Research.
Quotient Sciences has 2 investors. Key investors include Permira, and Bridgepoint Capital.